Showing results (1741-1750 of 2,132) with videos related to
Sort By:
Pageof 214
The American Journal of Psychiatry|December 11, 2024
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 TrialsWilliam P Horan, Colin Sauder, Philip D Harvey, et al.Pediatrics|July 31, 2013
Mask versus nasal tube for stabilization of preterm infants at birth: a randomized controlled trialC Omar F Kamlin, Kim Schilleman, Jennifer A Dawson, et al.Aging|August 10, 2013
Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or enduranceLan Ye, Anne L Widlund, Carrie A Sims, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2022
Cognitive Impairment in Tuberculous MeningitisAngharad G Davis, Anna J Dreyer, Christine Albertyn, et al.Nature Structural & Molecular Biology|June 14, 2005
Structural dissection and high-throughput screening of mannosylglycerate synthaseJames Flint, Edward Taylor, Min Yang, et al.Current Problems in Cardiology|January 23, 2023
COVID-19 With Stress Cardiomyopathy Mortality and Outcomes Among Patients Hospitalized in the United States: A Propensity Matched Analysis Using the National Inpatient Sample DatabaseMonique G Davis, Aniesh Bobba, Harris Majeed, et al.Antimicrobial Agents and Chemotherapy|January 18, 2002
Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirusPaula M Krosky, Katherine Z Borysko, M Reza Nassiri, et al.British Journal of Cancer|May 6, 2010
Family history of cancer and renal cell cancer risk in Caucasians and African AmericansS Karami, K Schwartz, M P Purdue, et al.Chemical Communications (Cambridge, England)|September 30, 2009
Saturation transfer difference NMR reveals functionally essential kinetic differences for a sugar-binding repressor proteinIgnacio Pérez-Victoria, Sebastian Kemper, Mitul K Patel, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 28, 2014
Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trialAlastair Carruthers, Suzanne Bruce, Arlette de Coninck, et al.Pageof 214